Collegium Pharmaceutical, Inc. (COLL)
48.36
-0.50
(-1.02%)
USD |
NASDAQ |
Dec 11, 16:00
48.35
-0.01
(-0.02%)
After-Hours: 20:00
Collegium Pharmaceutical Cash from Investing (Quarterly): -30.87M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.00 |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Altimmune, Inc. | -149.32M |
| Vertex Pharmaceuticals, Inc. | -117.00M |
| Viking Therapeutics, Inc. | 160.02M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 78.44M |
| Cash from Financing (Quarterly) | -14.82M |
| Free Cash Flow | 289.30M |
| Free Cash Flow Per Share (Quarterly) | 1.984 |
| Free Cash Flow to Equity (Quarterly) | 93.72M |
| Free Cash Flow to Firm (Quarterly) | 94.04M |
| Free Cash Flow Yield | 15.80% |